Trial Profile
An Open-label, Randomized, Two-period Crossover Study to Evaluate the Effect of Multiple Doses of Ketoconazole on the Pharmacokinetics of Darexaban and Metabolites in Young Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Feb 2018
Price :
$35
*
At a glance
- Drugs Darexaban (Primary)
- Indications Thrombosis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 02 Aug 2011 New trial record